SCHEMBL8282000

SCHEMBL8282000

Cc1ccnc(-c2ccc(F)c(N)c2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
ESR2 Q92731 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MAP4K4 O95819 1/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
TP53 P04637 1/20 0.40
PKM P14618 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
IRAK4 Q9NWZ3 2/20 0.39
CYP1A1 P04798 1/20 0.37
ALOX5AP P20292 2/20 0.37
FEN1 P39748 2/20 0.37
TGFBR1 P36897 1/20 0.35
BRD4 O60885 1/20 0.35
MPL P40238 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22130225 0.87 KIT (0.41) HSD17B10LMNAMAPTCYP2C9CYP2C19
SCHEMBL2666284 0.83 MEN1 (0.40) CYP2C9CYP2C19MAP4K4NPC1RAB9A
SCHEMBL3342664 0.83 RAB9A (0.44) HSD17B10LMNAMAPTTDP1NPC1
SCHEMBL8226435 0.81 RXRA (0.44) NPC1RAB9AIRAK4TGFBR1MEN1
SCHEMBL12021925 0.81 MEN1 (0.34) NPC1RAB9AIRAK4ALOX5APFEN1
SCHEMBL2666270 0.81 KMO (0.47) MAPTTP53SMN1; SMN2MEN1KMT2A
SCHEMBL8221626 0.78 GRIN2B (0.35) NPC1RAB9AIRAK4ALOX5APFEN1
SCHEMBL2666243 0.77 KMO (0.47) GRM5
SCHEMBL22578238 0.77 CYP1A2 (0.47) HSD17B10LMNAMAPTNPC1RAB9A
SCHEMBL10864552 0.77 IRAK4 (0.39) HSD17B10CYP2C9CYP2C19TDP1MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745047-B1 PYRAZOLO[4,3-E]-1,2,4-TRIAZOLO[1,5-C]PYRIMIDINE ADENOSINE-A2A- RECEPTOR ANTAGONISTS SCHERING CORP (US) 2010-03-24 EP disclosed
WO-2005103055-A1 PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PYRIMIDINE ADENOSINE A2A RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2005-11-03 WO disclosed